Heron Therapeutics reported $-62923000 in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Amarin AMRN:US -37619000 9.31M
Anika Therapeutics ANIK:US $ -3381000 173K
Arrowhead Research ARWR:US $ -72909000 114.46M
Eisai 4523:JP 7.43B 28.23B
Emergent Biosolutions EBS:US $ -72000000 78.4M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
GlaxoSmithKline GSK:LN 1.82B 600M
Immunogen IMGN:US $ -61053000 38.2M
Insmed INSM:US $ -100938000 513K
JAZZ PHA JAZZ:US 126.35M 38.8M
Merk MRK:US $ 5711M 652M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Pacira Pharmaceuticals PCRX:US $ 13.18M 8.55M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Sangamo Biosciences SGMO:US $ -45734000 473K
Surmodics SRDX:US $ -7143000 2.24M
Teva Pharmaceutical Industries TEVA:US 734M 55M
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
Veracyte VCYT:US $ -7433000 7.82M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M